NFKB1 and colonic neoplasm: Similarly, our lab showed that the administration of PKCι inhibitor, CRT0066854, significantly reduced the expression of NF-κB target genes such as Chemokine (C-C motif) ligand 20 (CCL20) and IL-8 and decreased colon cancer cells’ growth and migration [50].